Literature DB >> 19563830

Molecular basis of binding of the Plasmodium falciparum receptor BAEBL to erythrocyte receptor glycophorin C.

Lubin Jiang1, Sai Duriseti, Peter Sun, Louis H Miller.   

Abstract

Plasmodium falciparum invades human erythrocytes by redundant pathways. Unlike Plasmodium vivax that has one Duffy Binding-Like (DBL) receptor, P. falciparum has four members of the DBL receptor family. Furthermore, one of these DBL genes, BAEBL, has polymorphisms at four amino acids in region II; each polymorphism binds to a different erythrocyte receptor. One BAEBL variant (VSTK) binds specifically to erythrocyte glycophorin C and binds poorly to neuraminidase-treated erythrocytes. When the amino acid threonine (T121) in BAEBL (VSTK) is changed to a lysine (VSKK), it no longer requires sialic acid as a receptor. To explore the molecular basis of sialic acid binding, we modeled the structure of region II of BAEBL (VSTK) on the crystal structure of a related DBL receptor, region II of erythrocyte binding antigen-175 (EBA-175). Four charged amino acids, R52, R114, E54 and D125, are predicted to surround T121 in BAEBL (VSTK). They were individually mutated to alanine (R52A, R114A, E54A, and D125A) or lysine (R52K, R114K) and expressed on the surface of Chinese hamster ovary (CHO-K1) cells. BAEBL (VSTK) with mutations in R52 or R114 of BAEBL (VSTK) bound neuraminidase-treated erythrocytes. Unlike the arginine mutations, E54A and D125A still bound poorly to neuraminidase-treated erythrocytes. These findings suggest that the two arginine residues surrounding T121 are critical for the binding specificity of BAEBL (VSTK) to sialic acid and suggest a role for arginine in sialic acid binding independent of its negative charge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563830      PMCID: PMC2744354          DOI: 10.1016/j.molbiopara.2009.06.006

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  19 in total

1.  Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.

Authors:  N K Sauter; J E Hanson; G D Glick; J H Brown; R L Crowther; S J Park; J J Skehel; D C Wiley
Journal:  Biochemistry       Date:  1992-10-13       Impact factor: 3.162

2.  A method for freezing and washing red blood cells using a high glycerol concentration.

Authors:  H T Meryman; M Hornblower
Journal:  Transfusion       Date:  1972 May-Jun       Impact factor: 3.157

3.  Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea.

Authors:  P A Zimmerman; I Woolley; G L Masinde; S M Miller; D T McNamara; F Hazlett; C S Mgone; M P Alpers; B Genton; B A Boatin; J W Kazura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Red cell antigen, serum protein and red cell enzyme polymorphisms in Karkar Islanders and inhabitants of the adjacent North Coast of New Guinea.

Authors:  P B Booth; D Tills; A Warlow; A C Kopeć; A E Mourant; P Teesdale; R W Hornabrook
Journal:  Hum Hered       Date:  1982       Impact factor: 0.444

5.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy.

Authors:  L H Miller; S J Mason; D F Clyde; M H McGinniss
Journal:  N Engl J Med       Date:  1976-08-05       Impact factor: 91.245

6.  Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite.

Authors:  M Aikawa; L H Miller; J Johnson; J Rabbege
Journal:  J Cell Biol       Date:  1978-04       Impact factor: 10.539

7.  The glycophorin C N-linked glycan is a critical component of the ligand for the Plasmodium falciparum erythrocyte receptor BAEBL.

Authors:  D C Ghislaine Mayer; Lubin Jiang; Rajeshwara N Achur; Ikuko Kakizaki; D Channe Gowda; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

8.  A family of erythrocyte binding proteins of malaria parasites.

Authors:  J H Adams; B K Sim; S A Dolan; X Fang; D C Kaslow; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.

Authors:  Ian A Cockburn; Margaret J Mackinnon; Angela O'Donnell; Stephen J Allen; Joann M Moulds; Moses Baisor; Moses Bockarie; John C Reeder; J Alexandra Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

10.  Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity.

Authors:  D C Ghislaine Mayer; Jian-Bing Mu; Osamu Kaneko; Junhui Duan; Xin-zhuan Su; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  13 in total

1.  Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.

Authors:  Ivo M B Francischetti; Carlo J Oliveira; Graciela R Ostera; Stephanie B Yager; Françoise Debierre-Grockiego; Vanessa Carregaro; Giovanna Jaramillo-Gutierrez; Jen C C Hume; Lubin Jiang; Samuel E Moretz; Christina K Lin; José M C Ribeiro; Carole A Long; Brandi K Vickers; Ralph T Schwarz; Karl B Seydel; Massimo Iacobelli; Hans C Ackerman; Prakash Srinivasan; Regis B Gomes; Xunde Wang; Robson Q Monteiro; Michail Kotsyfakis; Anderson Sá-Nunes; Michael Waisberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

2.  Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites.

Authors:  Sash Lopaticki; Alexander G Maier; Jennifer Thompson; Danny W Wilson; Wai-Hong Tham; Tony Triglia; Alex Gout; Terence P Speed; James G Beeson; Julie Healer; Alan F Cowman
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

3.  Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine.

Authors:  Lubin Jiang; Deepak Gaur; Jianbing Mu; Hong Zhou; Carole A Long; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Molecular basis for sialic acid-dependent receptor recognition by the Plasmodium falciparum invasion protein erythrocyte-binding antigen-140/BAEBL.

Authors:  Brian M Malpede; Daniel H Lin; Niraj H Tolia
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

6.  Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains.

Authors:  Tony Triglia; Lin Chen; Sash Lopaticki; Chaitali Dekiwadia; David T Riglar; Anthony N Hodder; Stuart A Ralph; Jake Baum; Alan F Cowman
Journal:  PLoS Pathog       Date:  2011-06-16       Impact factor: 6.823

7.  The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity.

Authors:  Joanna Rydzak; Radoslaw Kaczmarek; Marcin Czerwinski; Jolanta Lukasiewicz; Jolanta Tyborowska; Boguslaw Szewczyk; Ewa Jaskiewicz
Journal:  PLoS One       Date:  2015-01-14       Impact factor: 3.240

8.  Identification of Bartonella Trw host-specific receptor on erythrocytes.

Authors:  Hon Kuan Deng; Danielle Le Rhun; Evelyne Le Naour; Sarah Bonnet; Muriel Vayssier-Taussat
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

9.  The epitope of monoclonal antibodies blocking erythrocyte invasion by Plasmodium falciparum map to the dimerization and receptor glycan binding sites of EBA-175.

Authors:  Xavier Ambroggio; Lubin Jiang; Joan Aebig; Harold Obiakor; Jan Lukszo; David L Narum
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

10.  A novel Plasmodium falciparum rhoptry associated adhesin mediates erythrocyte invasion through the sialic-acid dependent pathway.

Authors:  Gaurav Anand; K Sony Reddy; Alok Kumar Pandey; Syed Yusuf Mian; Hina Singh; Shivani Arora Mittal; Emmanuel Amlabu; Quique Bassat; Alfredo Mayor; Virander Singh Chauhan; Deepak Gaur
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.